These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 25651738

  • 1. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S, Zhang G, Xu J, Zhu X, Lu X, Jiang L, Wang Q, Hou X, Cao J, Ge M.
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [Abstract] [Full Text] [Related]

  • 2. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
    Hou X, Jiang L, Chen C, Zhu X, Ge M.
    Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
    [Abstract] [Full Text] [Related]

  • 3. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL, Zhang H, Chen YL, Peng L.
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar 08; 46(3):160-165. PubMed ID: 28297755
    [Abstract] [Full Text] [Related]

  • 4. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
    Sun L, Wang DM, Zhang WJ, Zhang J, Wu JF.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan 20; 31(2):123-126. PubMed ID: 29871201
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W, Li J, Zhang H, Huang Y, He L, Wang Z, Shan Z, Teng W.
    Int J Clin Exp Pathol; 2015 Jan 20; 8(6):7149-56. PubMed ID: 26261608
    [Abstract] [Full Text] [Related]

  • 6. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
    Chen X, Jin J, Zheng L, Sheng Y, Sun J.
    J BUON; 2021 Jan 20; 26(1):259-265. PubMed ID: 33721460
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS, Lee JJ, Do SI, Kim K, Do IG, Kim DH, Chae SW, Sohn JH.
    Int J Clin Exp Pathol; 2015 Jan 20; 8(5):5695-701. PubMed ID: 26191283
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
    Song Q, Wang D, Lou Y, Li C, Fang C, He X, Li J.
    Diagn Pathol; 2011 Dec 21; 6():126. PubMed ID: 22188859
    [Abstract] [Full Text] [Related]

  • 9. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S, Veyhl J, Jessa F, Polyakova O, Alenzi A, MacMillan C, Ralhan R, Walfish PG.
    Oncotarget; 2016 May 31; 7(22):32318-28. PubMed ID: 27086918
    [Abstract] [Full Text] [Related]

  • 10. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ, Su YR, Liu D, Xu DB, Zeng MS, Chen WK.
    J Surg Res; 2014 Dec 31; 192(2):487-93. PubMed ID: 24974154
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY, Zhang Q, Li Q, Lin S, Li J.
    J Int Med Res; 2014 Jun 31; 42(3):619-27. PubMed ID: 24670538
    [Abstract] [Full Text] [Related]

  • 12. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
    Qi L, He W.
    Med Sci Monit; 2018 Mar 06; 24():1373-1378. PubMed ID: 29509725
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients.
    Ma H, Li L, Li K, Wang T, Zhang Y, Zhang C, Xu Y, Wu X, Yu J, Wang H, Xiang B, Zhang R, Wang W.
    Neoplasma; 2018 Mar 14; 65(3):436-440. PubMed ID: 29788738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
    Nunes LM, Ayres FM, Francescantonio IC, Saddi VA, Avelino MA, Alencar Rde C, Silva RC, Meneghini AJ, Wastowski IJ.
    Hum Immunol; 2013 Apr 14; 74(4):447-51. PubMed ID: 23261411
    [Abstract] [Full Text] [Related]

  • 17. Correlations of ultrasound and pathological features of thyroid carcinoma with TC-1 mRNA and protein expression.
    Zhang CL, Geng CH, Jian JJ, He M, Zhao HW, Li HY.
    Eur Rev Med Pharmacol Sci; 2019 Apr 14; 23(8):3440-3446. PubMed ID: 31081098
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of CX3CL1 and CX3CR1 in papillary thyroid carcinoma.
    Wu W, Ren F, Guo M, Yang J, Xiao Y, Liu W.
    Histol Histopathol; 2020 Oct 14; 35(10):1189-1196. PubMed ID: 32975307
    [Abstract] [Full Text] [Related]

  • 19. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y, Li C, Luo DC, Ding JW, Zhang W, Pan G.
    Molecules; 2014 Aug 05; 19(8):11586-99. PubMed ID: 25100252
    [Abstract] [Full Text] [Related]

  • 20. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G, Huang J, Zhang H, Zhang W, Wu J, Shang X.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan 05; 28(2):108-12. PubMed ID: 24738314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.